
    
      The aim of this study is to

        1. Describe the incidence of symptomatic pandemic influenza infection in participants
           receiving neuraminidase inhibitor prophylaxis in the context of a place of employment or
           a profession

        2. Describe the incidence of seroconversion to pandemic influenza

        3. Describe the incidence of adverse events in volunteers taking long term antiviral
           prophylaxis

        4. Compare the effectiveness of oseltamivir and zanamivir prophylaxis

      The study is an open label prospective cohort study. Participants in this study will be
      health care and other essential workers receiving long term neuraminidase inhibitor
      prophylaxis.
    
  